📰 Omar Ram News
Page 2 - Omar Ram News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Omar Ram. Real-time updates on events, politics, business and more.
January 4, 2023
Carlos Gallardo, Chairman of Almirall, will represent the company in a session scheduled at 9am Pacific Standard Time on January 10th, 2023 Almirall, S.A. (ALM), a global biopharmaceutical
December 27, 2022
So what are you driving? Would a theft ring be targeting your particular vehicle?
November 10, 2022
Almirall achieves core net sales of €633.8 MM Euros in the first nine months of 2022 showing a solid 5.3% growth Almirall continues solid business momentum in Q3 with an acceleration of sales
October 28, 2022
Almirall’s Shedding Light on Psoriasis campaign exposes the impact of this disease on the mental health and wellbeing
August 13, 2022
Ciudad Juárez, Mexico, Aug 12 (EFE).- A day after Mexico’s border city Ciudad Juárez experienced its most violent day of the year when a prison clash spilled into the streets, leaving at least 11 dead, organizations and the public called on authorities Friday to ensure the perpetrators do not go unpunished. The violence began with …
July 13, 2022
So what are you driving? Would a theft ring be targeting your particular vehicle?
June 14, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
June 25, 2021
The mayor-elect of a small town in Mexico has been arrested for allegedly masterminding the killing of the candidate he replaced in the June 6 elections…
May 21, 2021
Almirall receives positive CHMP opinion for Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) of the face or scalp and it acts through a selective antiproliferative mechanism of action The positive opinion is based on the results from two pivotal phase III clinical trials which demonstrated complete clearance of AK lesions at day 57 in treated...
February 17, 2021
(1) In this collaboration Almirall will commercialize Wynzora Cream for treatment of plaque psoriasis in Europe and MC2 Therapeutics will be responsible for manufacturing and supply. MC2 Therapeutics and Almirall partner to make Wynzora Cream a leading topical product for Plaque Psoriasis in Europe In a large European based Phase 3 clinical trial (n=490), Wynzora Cream has demonstrated substantial efficacy with a PGA treatment success of 51% and beneficial treatment convenience 1 Cream h...